The Drug Ontology
Countries that developed this resource United States
Created in 2013
How to cite this record FAIRsharing.org: DrOn; The Drug Ontology; DOI: https://doi.org/10.25504/FAIRsharing.w5ntfd; Last edited: Oct. 5, 2020, 4:27 p.m.; Last accessed: Apr 12 2021 10:11 p.m.
Record added: Feb. 25, 2015, 8:55 p.m.
Record updated: Oct. 5, 2020, 4:27 p.m. by The FAIRsharing Team.
Edits to 'https://fairsharing.org/FAIRsharing.w5ntfd' by 'The FAIRsharing Team' at 16:27, 05 Oct 2020 (not approved): 'user_defined_tags' has been modified: Before: Approved drug After: Added: Removed: Approved drug 'onto_domains' has been modified: Before: drug small molecule After: Approved drug drug small molecule Added: Approved drug Removed:
Edits to 'https://fairsharing.org/FAIRsharing.w5ntfd' by 'The FAIRsharing Team' at 08:34, 29 Mar 2017 (approved): 'bioportal_abbreviation' has been modified: Before: DRON After: DRON
Edits to 'https://fairsharing.org/FAIRsharing.w5ntfd' by 'The FAIRsharing Team' at 19:49, 04 Sep 2016 (approved): 'description' has been modified: Before: An ontology of drug products and packaged drug products After: An ontology of drug products and packaged drug products.
No XSD schemas defined
Conditions of UseApplies to: Data use
Building a drug ontology based on RxNorm and other sources.
Hanna J,Joseph E,Brochhausen M,Hogan WR
J Biomed Semantics 2013
Therapeutic indications and other use-case-driven updates in the drug ontology: anti-malarials, anti-hypertensives, opioid analgesics, and a large term request
Hogan WR, Hanna J, Hicks A, Amirova S, Bramblett B, Diller M, Enderez R, Modzelewski T, Vasconcelos M, Delcher C
Journal of Biomedical Semantics 2017
An accurate and precise representation of drug ingredients
Hanna J, Bian J, Hogan WR
Journal of Biomedical Semantics 2016
No guidelines defined
Models and Formats
No syntax standards defined
No identifier schema standards defined
No metrics standards defined
The Open Biological and Biomedical Ontology (OBO) Foundry is a collective of ontology developers that are committed to collaboration and adherence to shared principles. The mission of the OBO Foundry is to develop a family of interoperable ontologies that are both logically well-formed and scientifically accurate. To achieve this, OBO Foundry participants voluntarily adhere to and contribute to the development of an evolving set of principles including open use, collaborative development, non-overlapping and strictly-scoped content, and common syntax and relations, based on ontology models that work well, such as the Gene Ontology (GO). The OBO Foundry is overseen by an Operations Committee with Editorial, Technical and Outreach working groups.
This record is not implemented by any policy.